OverviewChartNewsTraderScreen

Goldman Sachs Call 380 VRTX 17.05.../  DE000GG6XVQ6  /

EUWAX
2024-05-06  9:50:13 AM Chg.-0.02 Bid5:48:23 PM Ask5:48:23 PM Underlying Strike price Expiration date Option type
2.37EUR -0.84% 2.41
Bid Size: 5,000		 2.51
Ask Size: 5,000		 Vertex Pharmaceutica... 380.00 USD 2024-05-17 Call
GlobeNewswire 04-30 American Kidney Fund Encourages People to Be APOL1 Aware with First Annual APOL1-Mediated Kidney Dis...
GlobeNewswire 04-27 SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLC Investigates MODN, AIRC, INRD, ALPN
GlobeNewswire 04-25 American Kidney Fund Launches National Kidney Health Equity Media Campaign
GlobeNewswire 04-22 TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - ALPN, LABP, SWAV, FUS...
GlobeNewswire 04-22 CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASG...
GlobeNewswire 04-22 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INRD, AIRC, ELYM, ALPN
GlobeNewswire 04-22 Kuehn Law Encourages INRD, AIRC, ELYM, and ALPN Investors to Contact Law Firm
GlobeNewswire 04-20 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ADTH, MODN, ALPN
GlobeNewswire 04-16 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGRC, ALPN, NXPL
GlobeNewswire 04-13 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MODN, ALPN, ELYM, JBT
GlobeNewswire 04-09 American Kidney Fund and Alonzo Mourning Call for More Awareness and Understanding of APOL1-Mediated...
GlobeNewswire 04-03 CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference
GlobeNewswire 04-01 CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
GlobeNewswire 04-01 CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Me...
GlobeNewswire 03-15 American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...
GlobeNewswire 03-13 CRISPR Therapeutics Proposes New Appointment to the Board of Directors
GlobeNewswire 03-13 Entrada Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 03-12 MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
GlobeNewswire 03-12 UNCF 80th Anniversary Gala in Boston Raises More than $750K to Support HBCUs and Students
GlobeNewswire 02-29 New England UNCF “A Mind Is…” Gala to Celebrate UNCF’s 80th Anniversary
GlobeNewswire 02-29 Kidney Month: 31 Day of Action to Equip and Empower People to Fight Kidney Disease
GlobeNewswire 02-28 Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates
GlobeNewswire 02-27 Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financia...
GlobeNewswire 02-26 Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as...
GlobeNewswire 02-21 CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial...